These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 1840461

  • 1. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL, Delcayre C, Besnard JC, Paolaggi F, Mouas C, Swynghedauw B.
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [Abstract] [Full Text] [Related]

  • 2. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
    Tiritilli A, Ruff F.
    Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
    [Abstract] [Full Text] [Related]

  • 3. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K, Nakata T, Kuwabara T, Itoh H, Yamahara Y, Takesako T, Tanabe S, Sasaki S, Asayama J, Nakagawa M.
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [Abstract] [Full Text] [Related]

  • 4. [Effects of tetrandrine on cardiac hemodynamics of hypertrophied left ventricle from deoxycorticosterone-salt hypertensive rats].
    Xu Y, Rao MR.
    Yao Xue Xue Bao; 1995; 30(2):86-92. PubMed ID: 7785436
    [Abstract] [Full Text] [Related]

  • 5. Anoxia-induced changes in ventricular diastolic compliance in two models of hypertension in rats.
    Callens-el Amrani F, Snoeckx L, Swynghedauw B.
    J Hypertens; 1992 Mar; 10(3):229-36. PubMed ID: 1315819
    [Abstract] [Full Text] [Related]

  • 6. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
    O'Brien D, Chunduri P, Iyer A, Brown L.
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
    [Abstract] [Full Text] [Related]

  • 7. Normal left ventricular diastolic compliance after regression of hypertrophy.
    Schraeger JA, Canby CA, Rongish BJ, Kawai M, Tomanek RJ.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
    [Abstract] [Full Text] [Related]

  • 8. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A, Fenning A, Levick S, Hoey A, Brown L.
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [Abstract] [Full Text] [Related]

  • 9. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L, Ooi SY, Lau K, Sernia C.
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
    Iyer A, Woodruff TM, Wu MC, Stylianou C, Reid RC, Fairlie DP, Taylor SM, Brown L.
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
    Mirkovic S, Seymour AM, Fenning A, Strachan A, Margolin SB, Taylor SM, Brown L.
    Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
    [Abstract] [Full Text] [Related]

  • 12. Increased calcium influx mediates increased cardiac stiffness in hyperthyroid rats.
    Levick S, Fenning A, Brown L.
    Cell Biochem Biophys; 2005 Feb; 43(1):53-60. PubMed ID: 16043883
    [Abstract] [Full Text] [Related]

  • 13. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
    Ebrahim Z, Yellon DM, Baxter GF.
    Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
    [Abstract] [Full Text] [Related]

  • 14. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    Chan V, Hoey A, Brown L.
    Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
    [Abstract] [Full Text] [Related]

  • 15. Effect of treppe on isovolumic function in the isolated blood-perfused mouse heart.
    Brooks WW, Apstein CS.
    J Mol Cell Cardiol; 1996 Aug; 28(8):1817-22. PubMed ID: 8877791
    [Abstract] [Full Text] [Related]

  • 16. [The diastolic pressure-volume relationship of the left ventricle--evaluation of canine isovolumetric contracting left ventricle].
    Murakami R.
    Hokkaido Igaku Zasshi; 1985 Jan; 60(1):114-24. PubMed ID: 3988229
    [Abstract] [Full Text] [Related]

  • 17. Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat.
    Gerdes AM, Moore JA, Bishop SP.
    Can J Cardiol; 1985 Jan; 1(5):340-5. PubMed ID: 2945626
    [Abstract] [Full Text] [Related]

  • 18. Regression of left ventricular hypertrophy and susceptibility to reperfusion-induced arrhythmias after DOCA-salt hypertension in the rat.
    Baxter GF, Yellon DM.
    Cardioscience; 1992 Dec; 3(4):245-50. PubMed ID: 1477292
    [Abstract] [Full Text] [Related]

  • 19. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts.
    Kojda G, Kottenberg K, Stasch JP, Schrör K, Noack E.
    Br J Pharmacol; 1997 Nov; 122(5):813-20. PubMed ID: 9384495
    [Abstract] [Full Text] [Related]

  • 20. Cardiac contractile and coronary flow reserves in deoxycorticosterone acetate-salt hypertensive rats.
    Yamamoto J, Tsuchiya M, Saito M, Ikeda M.
    Hypertension; 1985 Nov; 7(4):569-77. PubMed ID: 3159665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.